Document is current
Any future updates will be listed below
-
Authors
Kelly, Sarah
Liu, Xinxue
Theiss-Nyland, Katherine
Voysey, Merryn
Murphy, Sarah
Li, Grace https://orcid.org/0000-0002-6661-0421
Nyantaro, Mary
Gurung, Meeru
Basnet, Sudha
Pokhrel, Bhishma
Bijukchhe, Sanjeev M.
Eordogh, Agnes
Gombe, Ben
Kakande, Ayoub
Kerridge, Simon
Kimbugwe, Geofrey
Kusemererwa, Sylvia
Lubyayi, Lawrence
Luzze, Henry
Mazur, Olga
Mujadidi, Yama F.
Nabukenya, Shamim
Nagumo, Walter-Rodney
Nareeba, Tryphena
Noristani, Rabiullah
O’Reilly, Peter
Roberts, Andrew
Shah, Ganesh
Shrestha, Sonu
Shrestha, Laxman P.
Thapa, Surya B.
Kibengo, Freddie M.
Sharma, Arun K.
Elliott, Alison
Shrestha, Shrijana
Pollard, Andrew J.
-
Funding
Funding for this research was provided by:
Bill and Melinda Gates Foundation
- License Information
-
More Information
Article History
Received: 3 May 2022
Accepted: 26 June 2023
First Online: 21 July 2023
Declarations
:
: Ethical approval has been granted by the Oxford Tropical Research Ethics Committee (OxTREC) University of Oxford (OxTREC 12–20 and 13–20); PAHS & IOM/TU Institutional Review Boards; the Nepal Health Research Council (NHRC 95–2020); Uganda Virus Research Institute Research Ethics Committee (GC/127/19/12/754); Uganda National Council for Science and Technology (SS5205), London School and Hygiene Research Ethics Committee (Project ID-22537); the National Drug Authority, Uganda (CTA0142).
: Not applicable.
: AJP is chair of the UK Department of Health and Social Care’s Joint Committee on Vaccination and Immunisation but does not participate in policy advice on coronavirus vaccines, and is a member of the WHO Strategic Advisory Group of Experts (SAGE). AJP is an NIHR Senior Investigator. AJP is the chief investigator on clinical trials of Oxford University’s COVID-19 vaccine funded by NIHR.
